Background Clinical trials for identification of efficient and effective new diagnostic and
treatment modalities are needed to address disproportionately high burden of …

Summary The first Lancet Oncology Commission on Global Cancer Surgery was published
in 2015 and serves as a landmark paper in the field of cancer surgery. The Commission …

Background A significant barrier to conducting clinical trials is their high cost, which is driven
primarily by the time and resources required to activate trials and reach accrual targets. The …

Noncommunicable diseases are now recognized by the United Nations and WHO as a
major public health crisis. Cancer is a main part of this problem, and health care systems are …

Low-income and middle-income countries (LMICs) have a disproportionately high burden of
cancer and cancer mortality. The unique barriers to optimum cancer care in these regions …

Gynecologic malignancies affect women in low and middle-income countries (LMICs) at
equal or higher rates compared to high income countries (HICs), yet practice guidelines …

Background Finding new therapeutic uses for existing medicines could lead to safe,
affordable and timely new treatment options for patients with high medical needs. However …

Acute lymphoblastic leukemia (ALL), one of the prevalent types of carcinogenic disease, has
been seen a deadly illness exposing numerous patients across the world to potential threats …

PURPOSE This survey was conducted to assess the current research practices among the
14 members of the Federation of Asian Organizations for Radiation Oncology (FARO) …

Background: Cancer genomics, as an interdisciplinary research area within the Global
Cancer Research agenda, genomics and precision medicine, its important in research and …